Semisaturated nitrogen heterocycles, such as 3-pyrrolines and unsaturated azepanes, possess highly prized three-dimensional geometries for drug discovery. However, their divergent synthesis from simple, unactivated feedstocks remains a formidable challenge. Herein, we report a highly selective, titanium-catalyzed divergent radical deoxycyclization coupling of nitrosoarenes and 1,3-dienes. Following an initial aza-Diels–Alder cycloaddition, an in situ generated low-valent titanium(III) species mediates single-electron homolytic cleavage of the robust oxazine N–O bond, yielding a transient nitrogen-centered aminyl radical. By rationally tuning the solvent coordination sphere and chlorosilane dissociation kinetics, this radical’s trajectory is selectively directed down two orthogonal pathways: a 5-exo-tet cyclization to afford 3-pyrrolines (formal [4 + 1]) and a highly strained vinylaziridine-mediated aza-Claisen rearrangement to yield unsaturated azepanes (formal [4 + 3]). This radical-polar crossover protocol features broad functional group tolerance and enables a streamlined, cyanide-free synthesis of the antiarrhythmic drug candidate SU-13197. Comprehensive mechanistic studies, including EPR spin-trapping, support the crucial aminyl radical intermediacy and the important role of titanium coordination in orchestrating cascade divergence.
No takes yet. Share an insight, caveat, or question.
Xuan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: